SEASTAR MEDICAL HOLDING CORPORATION
August 11, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Margaret Sawicki
Re: SeaStar Medical Holding Corporation—Registration Statement on Form S-1 (File No. 333-289447)
Ladies and Gentlemen:
In accordance with Rule 460 and Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-289447) (the “Registration Statement”) of SeaStar Medical Holding Corporation. (the “Company”). We respectfully request that the Registration Statement be declared effective as of 9:00 a.m., Eastern Time, on August 12, 2025, or as soon as practicable thereafter.
The Registrant hereby authorizes Josh Erekson of Dorsey & Whitney LLP, counsel for the Registrant, to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm that event by calling Josh Erekson at (801) 933-4083.
| Very truly yours, | |
| SEASTAR MEDICAL HOLDING CORPORATION | |
| /s/ Eric Schlorff | |
| Eric Schlorff | |
| Chief Executive Officer |